NCT06239818 Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents
| NCT ID | NCT06239818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Health Science Center, Houston |
| Condition | Sports-related Concussion |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-04-17 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-04-17 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare effects of Photobiomodulation therapy (PBMt) to standard of care in adolescent athletes at risk for delayed recovery from subacute sports concussion, to substantiate the impact of subacute PBMt over time on functional and structural connectivity of the brain using advanced MRI sequences and to correlate the psychological and behavioral outcomes to neuroimaging findings
Eligibility Criteria
Inclusion Criteria: * current participants in a school- or club-sponsored sport (contact or non-contact) * access to wireless internet service at home * diagnosis of sports-related concussion (SRC) (according to consensus diagnostic criteria) by a licensed healthcare provider,3-7 days from the concussive injury at the time of enrolment * considered at-risk for protracted recovery based on Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) performance and symptom reporting on the Post-Concussion Symptom Scale (PCSS) Exclusion Criteria: * acute neurologic deterioration to a Glasgow Coma Scale score less than 13 * neurosurgical intervention * abnormal CT scan * concomitant extracranial injury worse than mild * pre-injury conditions which confound effects of SRC (e.g., epilepsy, schizophrenia, bipolar illness, mental deficiency, hospitalization for TBI) * substance dependence * inability to speak fluent English * Individuals who are taking benzodiazepines, anti-convulsants, mood stabilizers, stimulants, opioids, sleep aids, or other neuropsychiatric medications
Contact & Investigator
Summer Ott, PsyD
PRINCIPAL INVESTIGATOR
The University of Texas Health Science Center, Houston
Frequently Asked Questions
Who can join the NCT06239818 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Sports-related Concussion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06239818 currently recruiting?
Yes, NCT06239818 is actively recruiting participants. Contact the research team at Summer.D.Ott@uth.tmc.edu for enrollment information.
Where is the NCT06239818 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06239818 clinical trial?
NCT06239818 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Summer Ott, PsyD at The University of Texas Health Science Center, Houston. The trial plans to enroll 30 participants.